NGM·Healthcare·$126M·#202 / 520 in Healthcare
NYXH Nyxoah SA
52SPECULATIVE
CATEGORY BREAKDOWN
GROWTH100
QUALITY54
STABILITY14
VALUATION36
GOVERNANCE73
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+121.6%
100
> 50% strong
Gross Margin
Revenue retained after direct costs
63.1%
90
> 50% strong
Cash Runway
Months of cash at current burn rate
5 months
9
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
82.4%
26
< 25% strong
Price / Sales
Market cap relative to trailing revenue
12.6x
36
< 3x strong
Rule of 40
Growth rate plus operating margin
-706
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
37.0%
100
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+16.7%
20
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE NYXH WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when NYXH's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.